FDA Advises Restaurants and Retailers in Texas and Louisiana to Stop Selling or Serving Topway Enterprises (doing business as Kazy’s Gourmet) Seafood Products due to Listeria

The FDA conducted a routine facility inspection of Topway Enterprises Inc. in February 2019. During the inspection, the FDA collected 53 environmental samples, 31 of which tested positive for Listeria species. The FDA issued a notice (483), about the serious unsanitary conditions.  On July 11, 2019, the FDA advised that the company cease operations until additional corrective action is performed, and no contamination is detected at the facility. In June 2019, the Texas Department of State Health Services (DSHS) inspected a follow-up to FDA’s February facility inspection.  During the inspection, four of the environmental samples tested positive for L. monocytogenes, and state inspectors observed continuing sanitation and seafood safety compliance issues.  Topway Enterprises Inc. agreed to cease operations and recall products voluntarily. They also agreed to provide the FDA with any corrective action planned, before resuming operations. However, the FDA became aware that the company resumed production at its facility, without implementing adequate corrective actions to address the risks that were identified. Topway Enterprise Inc. and Kazy’s Gourmet RTE seafood products, including tuna and salmon for raw consumption, received from July 10 to July 13, 2019, may have been incorporated into sushi and distributed to restaurants in TX and LA from July 10 to July 13, 2019. These products are typically sold fresh and do not have a long shelf life, though they can be frozen to extend the shelf life. @ https://www.fda.gov/food/alerts-advisories-safety-information/fda-advises-restaurants-and-retailers-texas-and-louisiana-stop-selling-or-serving-topway-enterprises?utm_campaign=Topway%20Enterprises%20Inc.%207-18-2019%20Email&utm_medium=email&utm_source=Eloqua